TMBR(Delisted)
TimberยทAMEX
--
--(--)
TMBR Profile
Timber Pharmaceuticals, Inc.
A prescription and OTC products developer for the treatment of women's health and aesthetics dermatology
3 Mountain View Road, Suite 100, Warren, NJ 07059
--
Timber Pharmaceuticals, Inc., incorporated under the laws of Delaware, was originally established on August 30, 2010 in Nevada under the name of Thompson Design Company. The company has only one wholly-owned subsidiary, BioPharmX Corporation, a company incorporated in Nevada. Timber is a clinical-stage biopharmaceutical company focused on the development and commercialization of orphan skin disease treatments. The company's investigational therapies have proven mechanisms of action supported by decades of clinical experience and mature CMC (chemistry, manufacturing and control) and safety profiles. The company initially focused on developing non-systematic treatments for rare skin diseases, including congenital ichthyosis, or CI, including X-linked recessive CI, or XLRI, and autosomal recessive CI, or ARCI, and other sclerosing skin diseases.
